Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
First patient enrolled in randomized, placebo-controlled study
Bensheim, 24. October 2025 Neurodegenerative diseases represent one of the biggest challenges of our time. In Germany alone, there are …